As reported by Höftberger in 2013, in a study of anti-GBABR encephalitis (15), patients with coexisting additional NMDAR antibodies showed prominent psychiatric symptoms, whereas patients with coexisting GAD65 antibodies developed refractory seizures. This evidence concerns the gene GAD2 and viral encephalitis.